The best Side of sodium pentobarbital other names
The best Side of sodium pentobarbital other names
Blog Article
pentobarbital will reduce the extent or effect of etravirine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Keep an eye on.
There won't be any knowledge on pregnancy exposures in primates equivalent to periods before the 3rd trimester in humans.
pentobarbital will reduce the extent or effect of paclitaxel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Mysterious.
pentobarbital will lessen the level or effect of tramadol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Decreased AUC of tramadol along with the Energetic metabolite (O-desmethyltramadol) when coadministered with solid CYP3A4 and CYP2B6 inducers
Contraindicated (one)pentobarbital will decrease the extent or effect of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay away from coadministration. Potent or average CYP3A inducers may well lower cobimetinib systemic exposure by >eighty% and lessen its efficacy.
pentobarbital will reduce the level or effect of ritonavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will reduce the level or effect of isradipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
Aged patients may well react to barbiturates with marked enjoyment, despair, and confusion. In a few individuals, barbiturates check here continuously create exhilaration rather then melancholy. Dosage need to be minimized inside the aged due to the fact these patients could possibly be much more delicate to barbiturates.
pentobarbital will reduce the level or effect of nicardipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will decrease the level or effect of apremilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration with potent CYP inducers results in a substantial lessen of systemic publicity of apremilast, which can result in loss of efficacy
pentobarbital will minimize the level or effect of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib can be a sensitive CYP3A4 substrate. Coadministration with potent or average CYP3A4 inducers is contraindicated.
pentobarbital will reduce the extent or effect of terbinafine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will reduce the extent or effect of conivaptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will minimize the extent or effect of imatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.